• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    More On OPNT

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Opiant Pharmaceuticals, Inc. (OPNT)

    -Other OTC
    8.88 Down 0.02(0.22%) Apr 29, 3:49PM EDT
    Prev Close:8.90
    Open:8.90
    Bid:N/A
    Ask:N/A
    1y Target Est:42.67
    Beta:-0.044844
    Next Earnings Date:N/A
    Day's Range:8.78 - 8.95
    52wk Range:6.00 - 14.00
    Volume:3,788
    Avg Vol (3m):8,727
    Market Cap:17.21M
    P/E (ttm):N/A
    EPS (ttm):-9.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPNT

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-13) :N/A
    Quarterly EPS Est (Dec-12) :N/A
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops opioid antagonist treatments for addictions and related disorders. The company is involved in developing a treatment for reversal of opioid overdoses; a treatment for binge... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback